The U.S. Food and Drug Administration has limited the use of the Johnson & Johnson Janssen COVID-19 vaccine due to rare blood clotting instances of thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.
FDA limits use of the J&J Janssen COVID-19 vaccine
